LAUREN WENDLAND: Open Payments
NPI 1366901076 · SELMA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 16 payments from 9 companies in 2025. Trend: 2023 $340 · 2024 $280 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $96 |
| Novo Nordisk Inc | 5 | $84 |
| RADIOMETER AMERICA, INC | 1 | $40 |
| Abbott Laboratories | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: AIRSUPRA, HemoCue Glucose 201 DM Analyzer, FREESTYLE LIBRE 3, Ozempic, Rybelsus, XIFAXAN, Wegovy, Kerendia.
Industry payments across AL — which companies pay providers there.
